Let’s Talk About Compass And Psychedelic Capitalism

Wesley Thoricatha, writing for Psychedelic Times:

Be careful what you ask for, because you just might get it. Gaining scientific legitimacy, ending stigmas, and seeking mainstream acceptance have long been goals in the psychedelic community, but now that all of these things are happening, this relatively small and close-knit community is experiencing some growing pains. […]

Much of this concern has landed on one of the rising stars of the for-profit psychedelic world, the US/UK based Compass Pathways. Compass made news recently for securing FDA breakthrough medication status for psilocybin in the treatment of depression- a major win for psilocybin research and psychedelic acceptance in general- yet their tactics over the years and their financial backers have ruffled a few feathers along the way.

To seek insight on Compass and their critics, and to address the larger debate around psychedelics and capitalism, we spoke with Rick Doblin, founder of MAPS, champion of working within the system to promote psychedelics, and perhaps the most successful and impactful psychedelic advocate in modern history.

After all the talk about this lately, it’s refreshing to hear from Rick himself.